Arcus Biosciences, Inc. (RCUS) Financials

RCUS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 997.0 million 473.0 million
Dec. 31, 2025 1.1 billion 508.0 million
Sept. 30, 2025 974.0 million 538.0 million
June 30, 2025 1.1 billion 526.0 million

RCUS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -138.0 million 19.0 million
Dec. 31, 2025 -121.0 million 15.0 million
Sept. 30, 2025 -97.0 million 14.0 million
June 30, 2025 -133.0 million 15.0 million

RCUS Net Income

No data available :(

RCUS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 822.0 million 100.0 million -
Dec. 31, 2025 981.0 million 99.0 million 13.0 million
Sept. 30, 2025 831.0 million 98.0 million 13.0 million
June 30, 2025 911.0 million 97.0 million 12.0 million

RCUS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 125.4 million
Dec. 31, 2025 107.4 million
Sept. 30, 2025 106.5 million
June 30, 2025 106.5 million

RCUS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 122.0 million 29.0 million -
Dec. 31, 2025 1.0 million 121.0 million 26.0 million -
Sept. 30, 2025 - 141.0 million 27.0 million -
June 30, 2025 - 139.0 million 29.0 million -

RCUS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 17.0 million 2.0 million
Dec. 31, 2025 33.0 million 3.0 million
Sept. 30, 2025 26.0 million 2.0 million
June 30, 2025 160.0 million 2.0 million

RCUS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

RCUS

Price: $24.18

52 week price:
7.91
28.72

Earnings Per Share: -3.17 USD

Exchange: NYQ

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 965900

Market Capitalization: 2.3 billion

Links: